Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 223

1.

The role of rifaximin in the primary prophylaxis of spontaneous bacterial peritonitis in patients with liver cirrhosis.

Hanouneh MA, Hanouneh IA, Hashash JG, Law R, Esfeh JM, Lopez R, Hazratjee N, Smith T, Zein NN.

J Clin Gastroenterol. 2012 Sep;46(8):709-15. doi: 10.1097/MCG.0b013e3182506dbb.

PMID:
22878533
2.

Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites.

Lutz P, Parcina M, Bekeredjian-Ding I, Nischalke HD, Nattermann J, Sauerbruch T, Hoerauf A, Strassburg CP, Spengler U.

PLoS One. 2014 Apr 8;9(4):e93909. doi: 10.1371/journal.pone.0093909. eCollection 2014.

3.

The role of rifaximine in the prevention of the spontaneous bacterial peritonitis.

Dănulescu RM, Ciobică A, Stanciu C, Trifan A.

Rev Med Chir Soc Med Nat Iasi. 2013 Apr-Jun;117(2):315-20.

PMID:
24340510
4.

The efficacy and the immunomodulatory effect of rifaximin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic Egyptian patients.

Mostafa T, Badra G, Abdallah M.

Turk J Gastroenterol. 2015 Mar;26(2):163-9. doi: 10.5152/tjg.2015.7782.

5.

Spontaneous bacterial peritonitis by Pasteurella multocida under treatment with rifaximin.

Lutz P, Parcina M, Bekeredjian-Ding I, Hoerauf A, Strassburg CP, Spengler U.

Infection. 2014 Feb;42(1):175-7. doi: 10.1007/s15010-013-0449-4. Epub 2013 Mar 25.

PMID:
23526308
6.

Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.

Sandhu BS, Gupta R, Sharma J, Singh J, Murthy NS, Sarin SK.

J Gastroenterol Hepatol. 2005 Apr;20(4):599-605.

PMID:
15836710
7.

Oral antibiotic prophylaxis reduces spontaneous bacterial peritonitis occurrence and improves short-term survival in cirrhosis: a meta-analysis.

Saab S, Hernandez JC, Chi AC, Tong MJ.

Am J Gastroenterol. 2009 Apr;104(4):993-1001; quiz 1002. doi: 10.1038/ajg.2009.3. Epub 2009 Mar 10. Review.

PMID:
19277033
8.

Antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhotic patients with ascites, without gastro-intestinal bleeding.

Cohen MJ, Sahar T, Benenson S, Elinav E, Brezis M, Soares-Weiser K.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004791. doi: 10.1002/14651858.CD004791.pub2. Review.

PMID:
19370611
9.

Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.

Novella M, Solà R, Soriano G, Andreu M, Gana J, Ortiz J, Coll S, Sàbat M, Vila MC, Guarner C, Vilardell F.

Hepatology. 1997 Mar;25(3):532-6.

PMID:
9049193
10.
11.

A randomized controlled study of trimethoprim-sulfamethoxazole versus norfloxacin for the prevention of infection in cirrhotic patients.

Lontos S, Shelton E, Angus PW, Vaughan R, Roberts SK, Gordon A, Gow PJ.

J Dig Dis. 2014 May;15(5):260-7. doi: 10.1111/1751-2980.12132.

PMID:
24612987
12.
13.

Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.

Mandorfer M, Bota S, Schwabl P, Bucsics T, Pfisterer N, Summereder C, Hagmann M, Blacky A, Ferlitsch A, Sieghart W, Trauner M, Peck-Radosavljevic M, Reiberger T.

PLoS One. 2014 Nov 4;9(11):e110503. doi: 10.1371/journal.pone.0110503. eCollection 2014.

14.

[Spontaneous bacterial peritonitis in the patients with liver cirrhosis].

Jarcuska P, Veselíny E, Orolín M, Takácová V, Hancová M.

Klin Mikrobiol Infekc Lek. 2004 Dec;10(6):265-70. Slovak.

PMID:
15672324
15.

Role of fluoroquinolones in the primary prophylaxis of spontaneous bacterial peritonitis: meta-analysis.

Loomba R, Wesley R, Bain A, Csako G, Pucino F.

Clin Gastroenterol Hepatol. 2009 Apr;7(4):487-93. doi: 10.1016/j.cgh.2008.12.018. Epub 2008 Dec 27.

PMID:
19250986
16.

Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites.

Schwabl P, Bucsics T, Soucek K, Mandorfer M, Bota S, Blacky A, Hirschl AM, Ferlitsch A, Trauner M, Peck-Radosavljevic M, Reiberger T.

Liver Int. 2015 Sep;35(9):2121-8. doi: 10.1111/liv.12795. Epub 2015 Feb 18.

PMID:
25644943
17.

Norfloxacin and trimethoprim-sulfamethoxazole therapy have similar efficacy in prevention of spontaneous bacterial peritonitis.

Lontos S, Gow PJ, Vaughan RB, Angus PW.

J Gastroenterol Hepatol. 2008 Feb;23(2):252-5. Epub 2007 Jun 7.

PMID:
17559367
18.

Assessing the risk of decompensation by ascites and spontaneous bacterial peritonitis in cirrhosis.

Dănulescu RM, Stanciu C, Trifan A.

Rev Med Chir Soc Med Nat Iasi. 2014 Apr-Jun;118(2):320-6.

PMID:
25076694
19.

Long-term prophylaxis of spontaneous bacterial peritonitis in patients with cirrhosis.

Frazee LA, Marinos AE, Rybarczyk AM, Fulton SA.

Ann Pharmacother. 2005 May;39(5):908-12. Epub 2005 Mar 15. Review.

PMID:
15769829
20.

Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial.

Rolachon A, Cordier L, Bacq Y, Nousbaum JB, Franza A, Paris JC, Fratte S, Bohn B, Kitmacher P, Stahl JP, et al.

Hepatology. 1995 Oct;22(4 Pt 1):1171-4.

PMID:
7557868
Items per page

Supplemental Content

Write to the Help Desk